Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

GNRHR anticorps (N-Term)

L’anticorps Souris Monoclonal anti-GNRHR a été validé pour IF et FACS. Il convient pour détecter GNRHR dans des échantillons de Humain.
N° du produit ABIN6163408

Aperçu rapide pour GNRHR anticorps (N-Term) (ABIN6163408)

Antigène

Voir toutes GNRHR Anticorps
GNRHR (Gonadotropin-Releasing Hormone Receptor (GNRHR))

Reactivité

  • 68
  • 18
  • 12
  • 2
  • 1
Humain

Hôte

  • 42
  • 29
  • 1
Souris

Clonalité

  • 40
  • 32
Monoclonal

Conjugué

  • 35
  • 6
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp GNRHR est non-conjugé

Application

  • 27
  • 27
  • 25
  • 19
  • 11
  • 9
  • 8
  • 4
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Immunofluorescence (IF), Flow Cytometry (FACS)

Clone

A9E4
  • Épitope

    • 26
    • 25
    • 8
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-29, N-Term

    Fonction

    Mouse Monoclonal anti-GnRH Receptor (LHRH Receptor) (A9E4), Purified, BSA-free

    Attributs du produit

    This antibody recognizes an epitope on the extracellular domain of gonadotropin releasing hormone (GnRH) receptor or luteinizing hormone receptor (LHCGR). Lutropin (also designated luteinizing hormone) plays a role in spermatogenesis and ovulation by stimulating the testes and ovaries to produce steroids. Gonadotropin (also designated choriogonadotropin) production in the placenta maintains estrogen and progesterone levels during the first trimester of pregnancy. Ovaries and testes abundantly express luteinizing hormone/choriogonadotropin receptor. GnRH receptor contains seven hydrophobic transmembrane domains connected by hydrophilic extracellular and intracellular loops characteristic of G-protein coupled receptors. GnRH stimulates the gonadotrophs of the anterior pituitary to secrete luteinizing hormone (LH) as well as follicle-stimulating hormone (FSH). GnRH influences the protective effect of pregnancy and Gonadotropin against breast cancer. The expression of GnRH on breast carcinoma correlates in part to the degree of tumor differentiation. GnRH-positive breast tumors occur more frequently in tumors with greater cell differentiation in premenopausal women. GnRH is present in luteal and granulosa cells as well as in ovarian cell membrane preparations. Primary antibodies are available purified, or with a selection of fluorescent CF® dyes and other labels. CF® dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

    Purification

    Purified

    Immunogène

    A synthetic peptide aa 1-29 (MANSASPEQNQHCSAINNSIPLMQGNLPY) from the N-terminal of human GnRH receptor.

    Isotype

    IgG1 kappa
  • Indications d'application

    Flow Cytometry 0.5-1 μg/million cells/0.1 mL
    • Immunofluorescence 1-2 μg/mL
    • Predicted to react with pig or rabbit, others not known
    • Optimal dilution for a specific application should be determined by user

    Commentaires

    T47D cells. Pituitary gland, ovarian or breast cancers.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 mg/mL

    Buffer

    PBS (no BSA, no azide)

    Agent conservateur

    Azide free
  • Antigène

    GNRHR (Gonadotropin-Releasing Hormone Receptor (GNRHR))

    Autre désignation

    GnRH Receptor (LHRH Receptor)

    Poids moléculaire

    54-60 kDa
Vous êtes ici:
Chat with us!